Literature DB >> 7729898

Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.

F De Bernardis1, A Cassone, J Sturtevant, R Calderone.   

Abstract

Several strains of Candida albicans were compared for their ability to cause vaginal infection in a rat model, and their vaginopathic potentials were correlated with the expression of two aspartyl proteinases genes (SAP1 and SAP2) and adherence in vivo to the vaginal epithelium. Dot blot reactions and Northern blot analysis with RNA extracted from the vaginal fluid of rats infected with the highly vaginopathic strains H12 and 10261 demonstrated the expression of both SAP1 and SAP2 during the first week of infection. In contrast, neither gene was expressed during infection by a nonvaginopathic strain (N), even though the organism could be recovered during the first 24 h postinfection. A moderately vaginopathic strain (P) also expressed both genes, but the level of SAP1 mRNA appeared to decrease prior to that of SAP2. Neither gene was expressed, even by the highly vaginopathic strains, after the first week of infection, concomitant with a decrease in the number of organisms recovered from the vaginas. Analysis of in vivo adherence showed that the nonvaginopathic strain (N) adhered to vaginal epithelial cells less readily than the highly vaginopathic strain (H12) and moderately vaginopathic strain (P). Thus, in addition to its inability to express SAP1 and SAP2 in vivo, the nonvaginopathic strain does not colonize host cells to the same extent as the other strains tested. Our results demonstrate the early in vivo expression of two aspartyl proteinase gene during candidal vaginitis and suggest its association with the establishment of a vaginal infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729898      PMCID: PMC173239          DOI: 10.1128/iai.63.5.1887-1892.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis.

Authors:  M Borg; R Rüchel
Journal:  J Med Vet Mycol       Date:  1990

Review 2.  Fungal infections in patients with AIDS and AIDS-related complex.

Authors:  K Holmberg; R D Meyer
Journal:  Scand J Infect Dis       Date:  1986

3.  Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent.

Authors:  A M Edison; M Manning-Zweerink
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  Proteinase production and pathogenicity of Candida albicans. I. Invasion into chorioallantoic membrane by C. albicans strains of different proteinase activity.

Authors:  K Shimizu; Y Kondoh; K Tanaka
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

5.  Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.

Authors:  K J Kwon-Chung; D Lehman; C Good; P T Magee
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans.

Authors:  M Ghannoum; K Abu Elteen
Journal:  J Med Vet Mycol       Date:  1986-10

7.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Evidence for a correlation between proteinase secretion and vulvovaginal candidosis.

Authors:  A Cassone; F De Bernardis; F Mondello; T Ceddia; L Agatensi
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

9.  Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase.

Authors:  T L Ray; C D Payne
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Effect of pH and human saliva on protease production by Candida albicans.

Authors:  G R Germaine; L M Tellefson
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more
  30 in total

1.  Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection.

Authors:  C Kvaal; S A Lachke; T Srikantha; K Daniels; J McCoy; D R Soll
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Authors:  J R Naglik; G Newport; T C White; L L Fernandes-Naglik; J S Greenspan; D Greenspan; S P Sweet; S J Challacombe; N Agabian
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 4.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 5.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

Review 6.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

7.  High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women.

Authors:  F de Bernardis; F Mondello; G Scaravelli; A Pachì; A Girolamo; L Agatensi; A Cassone
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Authors:  A R Colina; F Aumont; N Deslauriers; P Belhumeur; L de Repentigny
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 9.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

10.  Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis.

Authors:  Christine J Morrison; Steven F Hurst; Errol Reiss
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.